Page last updated: 2024-08-22

n-methylaspartate and indantadol

n-methylaspartate has been researched along with indantadol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbieri, M; Bergamaschi, M; Bregola, G; Buzzi, A; Marino, S; Pietra, C; Simonato, M; Stables, JP; Villetti, G; Zucchini, S	1
Dostert, P; Fabbri, L; Guillevic, Y; Imbimbo, BP; Mariotti, F; Rondelli, I; Tarral, A	1
Coluzzi, F; Mattia, C	1

Reviews

1 review(s) available for n-methylaspartate and indantadol

Article	Year
Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain. IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:9 Topics: Analgesics; Animals; Anticonvulsants; Clinical Trials as Topic; Diabetic Neuropathies; Glycine; Humans; Indans; Monoamine Oxidase Inhibitors; N-Methylaspartate; Pain	2007

Trials

1 trial(s) available for n-methylaspartate and indantadol

Article	Year
Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects. Journal of clinical pharmacology, 2003, Volume: 43, Issue:8 Topics: Administration, Oral; Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Food; Glycine; Half-Life; Humans; Indans; Male; Memory; Metabolic Clearance Rate; N-Methylaspartate	2003

Article

Year

Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects.

Journal of clinical pharmacology, 2003, Volume: 43, Issue:8

Topics: Administration, Oral; Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Food; Glycine; Half-Life; Humans; Indans; Male; Memory; Metabolic Clearance Rate; N-Methylaspartate

2003

Other Studies

1 other study(ies) available for n-methylaspartate and indantadol

Article	Year
Mechanisms of action of CHF3381 in the forebrain. British journal of pharmacology, 2003, Volume: 139, Issue:7 Topics: Animals; Anticonvulsants; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electrophysiology; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Hippocampus; Indans; Injections, Intraperitoneal; Ion Channel Gating; Male; N-Methylaspartate; Neurons; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Sodium Channels	2003

Article

Year

Mechanisms of action of CHF3381 in the forebrain.

British journal of pharmacology, 2003, Volume: 139, Issue:7

Topics: Animals; Anticonvulsants; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electrophysiology; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Hippocampus; Indans; Injections, Intraperitoneal; Ion Channel Gating; Male; N-Methylaspartate; Neurons; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Sodium Channels

2003